Pages that link to "Q28292981"
Jump to navigation
Jump to search
The following pages link to The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial (Q28292981):
Displaying 50 items.
- Treatment of infantile spasms (Q24202185) (← links)
- Treatment of infantile spasms (Q24241001) (← links)
- H.p. Acthar gel and cosyntropin review: clinical and financial implications (Q24645310) (← links)
- Management of infantile spasms (Q26770301) (← links)
- Systematic review of the toxicity of short-course oral corticosteroids in children (Q26771977) (← links)
- Antiepileptic Drug Treatment in Children with Epilepsy (Q26781771) (← links)
- Epileptic encephalopathies: new genes and new pathways (Q27027982) (← links)
- Outcomes in treatment of infantile spasms with pulse methylprednisolone (Q30450126) (← links)
- The current evaluation and treatment of infantile spasms among members of the Child Neurology Society (Q30455995) (← links)
- Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation. (Q30489831) (← links)
- A pulse rapamycin therapy for infantile spasms and associated cognitive decline (Q30501073) (← links)
- Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society (Q30515135) (← links)
- Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms (Q30560643) (← links)
- Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics (Q30977510) (← links)
- Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective (Q33524561) (← links)
- Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trial (Q33608771) (← links)
- Infantile spasms: review of the literature and personal experience (Q33692321) (← links)
- Infantile Spasms Treated with Intravenous Methypredinsolone Pulse (Q33861597) (← links)
- Non-vision adverse events with vigabatrin therapy (Q34068916) (← links)
- Developing an animal model for infantile spasms: pathogenesis, problems and progress (Q34192123) (← links)
- Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents (Q34351304) (← links)
- Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma (Q34754791) (← links)
- Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms (Q35204540) (← links)
- Validation of the rat model of cryptogenic infantile spasms. (Q35204574) (← links)
- Corticosteroids in the management of the paediatric epilepsies (Q35283109) (← links)
- Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms (Q35399462) (← links)
- Applications of optical coherence tomography in pediatric clinical neuroscience (Q35620366) (← links)
- Phenobarbital for childhood epilepsy: systematic review (Q35677374) (← links)
- Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy (Q36153418) (← links)
- SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation (Q36369946) (← links)
- Safety and efficacy of vigabatrin for the treatment of infantile spasms (Q36873912) (← links)
- CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. (Q36930153) (← links)
- Antiepileptic drug development in children: considerations for a revisited strategy (Q37032549) (← links)
- Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity (Q37149913) (← links)
- Epileptic Encephalopathy in Infants and Children (Q37182454) (← links)
- Use of second-generation antiepileptic drugs in the pediatric population (Q37203259) (← links)
- Does the effectiveness of the ketogenic diet in different epilepsies yield insights into its mechanisms? (Q37339266) (← links)
- Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms (Q37373308) (← links)
- Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone (Q37524504) (← links)
- Cognition across the lifespan: antiepileptic drugs, epilepsy, or both? (Q37636800) (← links)
- Infantile spasms: a U.S. consensus report. (Q37770587) (← links)
- Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review (Q37808724) (← links)
- Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms (Q37815377) (← links)
- New Drugs for Pediatric Epilepsy (Q37823723) (← links)
- Pharmacotherapy for children and adolescents with epilepsy (Q37826193) (← links)
- Vigabatrin for Infantile Spasms (Q37848404) (← links)
- Immuno‐ and antiinflammatory therapies in epileptic disorders (Q37872033) (← links)
- Treatment of infantile spasms: emerging insights from clinical and basic science perspectives (Q37896402) (← links)
- Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies (Q37924842) (← links)
- Mechanism of action of vigabatrin: correcting misperceptions (Q37953574) (← links)